BDF Gestion’s Regeneron Pharmaceuticals REGN Stock Holding History

BDF Gestion’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.53M	Buy	3,335 +1,811	+119%	+$1.37M	0.34%	64
2026 Q2	$2.8M	Sell	1,524 -172	-10%	-$117K	0.38%	68
2026 Q1	$1.31M	Hold	1,696	–	–	0.18%	130
2025 Q4	$1.31M	Sell	1,696 -114	-6%	-$77.4K	0.16%	129
2025 Q3	$1.02M	Sell	1,810 -379	-17%	-$214K	0.12%	138
2025 Q2	$1.15M	Sell	2,189 -2,264	-51%	-$1.26M	0.13%	130
2025 Q1	$2.82M	Hold	4,453	–	–	0.31%	86
2024 Q4	$3.17M	Sell	4,453 -580	-12%	-$487K	0.33%	75
2024 Q3	$1.96M	Buy	+5,033	New	+$5.6M	0.21%	119

Other funds holding REGN

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return

BDF Gestion's REGN Position: Q3 2026 in Review

BDF Gestion increased its Regeneron Pharmaceuticals (REGN) stake by 119% in Q3 2026, buying an estimated $1.37M and bringing the position to 3,335 shares worth $2.53M. The position accounts for 0.34% of the portfolio, ranked #64.

BDF Gestion first reported a position in REGN in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.17M in Q4 2024. 207 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

BDF Gestion held 3,335 shares of Regeneron Pharmaceuticals worth $2.53M as of Q3 2026.
BDF Gestion bought 1,811 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $1.37M.
Regeneron Pharmaceuticals made up 0.34% of BDF Gestion's portfolio in Q3 2026, its #64 holding.
BDF Gestion first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
BDF Gestion's Regeneron Pharmaceuticals position peaked at $3.17M in Q4 2024.
207 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on BDF Gestion's 13F filing for Q3 2026, filed 19 Oct 2026.